The new study published in the Journal of Pediatric Gastroenterology and Nutrition has demonstrated that the InFat, a high beta-palmitate fat blend, provides health benefits for formula-fed infants.
InFat is a patented and clinically-proven fat blend for infant formula with a high percentage of palmitic acid in its sn-2 position.
A double-blind, randomized, multicenter study revealed a significant increase in Lactobacilli and Bifidobacteria abundance in the microbiota, shifting the flora composition to be more comparable to breastfed infants. This study was conducted at the Neonatology departments of Bnai Zion Medical Center, Haifa, Israel, and Meir Medical Center, Kfar Saba, Israel and sponsored by Enzymote.
The study was conducted to explore the affect of InFat on the intestinal flora of term infants.
Enzymotec Infant Nutrition R&D director Yael Lifshitz said that the InFat improves the infant formula and makes it similar to mother's milk in terms of infants' flora composition.
